BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38684876)

  • 1. Wnt/β-catenin signaling regulates amino acid metabolism through the suppression of CEBPA and FOXA1 in liver cancer cells.
    Nakagawa S; Yamaguchi K; Takane K; Tabata S; Ikenoue T; Furukawa Y
    Commun Biol; 2024 Apr; 7(1):510. PubMed ID: 38684876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs.
    Zhang H; Rong X; Wang C; Liu Y; Lu L; Li Y; Zhao C; Zhou J
    J Biol Chem; 2020 Dec; 295(49):16826-16839. PubMed ID: 32989053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
    Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
    J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
    Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
    Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of FERM domain-containing protein 5 as a novel target of β-catenin/TCF7L2 complex.
    Zhu C; Yamaguchi K; Ohsugi T; Terakado Y; Noguchi R; Ikenoue T; Furukawa Y
    Cancer Sci; 2017 Apr; 108(4):612-619. PubMed ID: 28117551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCAAT enhancer binding protein α suppresses proliferation, metastasis, and epithelial-mesenchymal transition of ovarian cancer cells via suppressing the Wnt/β-catenin signaling.
    Zhang LM; Li M; Tian CC; Wang TT; Mi SF
    Neoplasma; 2021 May; 68(3):602-612. PubMed ID: 33780265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart Failure.
    Hou N; Ye B; Li X; Margulies KB; Xu H; Wang X; Li F
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC.
    Cai Y; Lyu T; Li H; Liu C; Xie K; Xu L; Li W; Liu H; Zhu J; Lyu Y; Feng X; Lan T; Yang J; Wu H
    J Exp Clin Cancer Res; 2022 Dec; 41(1):335. PubMed ID: 36471363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-22-3p targeted regulating transcription factor 7-like 2 (TCF7L2) constrains the Wnt/β-catenin pathway and malignant behavior in osteosarcoma.
    Xue Y; Guo Y; Liu N; Meng X
    Bioengineered; 2022 Apr; 13(4):9135-9147. PubMed ID: 34753394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LGR6 activates the Wnt/β-catenin signaling pathway and forms a β-catenin/TCF7L2/LGR6 feedback loop in LGR6
    Feng Q; Li S; Ma HM; Yang WT; Zheng PS
    Oncogene; 2021 Oct; 40(42):6103-6114. PubMed ID: 34489551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling.
    Emons G; Spitzner M; Reineke S; Möller J; Auslander N; Kramer F; Hu Y; Beissbarth T; Wolff HA; Rave-Fränk M; Heßmann E; Gaedcke J; Ghadimi BM; Johnsen SA; Ried T; Grade M
    Mol Cancer Res; 2017 Nov; 15(11):1481-1490. PubMed ID: 28811361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linc00210 drives Wnt/β-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner.
    Fu X; Zhu X; Qin F; Zhang Y; Lin J; Ding Y; Yang Z; Shang Y; Wang L; Zhang Q; Gao Q
    Mol Cancer; 2018 Mar; 17(1):73. PubMed ID: 29540185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
    Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
    Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The developmental Wnt signaling pathway effector β-catenin/TCF mediates hepatic functions of the sex hormone estradiol in regulating lipid metabolism.
    Tian L; Shao W; Ip W; Song Z; Badakhshi Y; Jin T
    PLoS Biol; 2019 Oct; 17(10):e3000444. PubMed ID: 31589598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma.
    Sun X; Cai M; Wu L; Zhen X; Chen Y; Peng J; Han S; Zhang P
    Cancer Sci; 2022 Oct; 113(10):3463-3475. PubMed ID: 35880246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wnt3a/β-catenin/TCF7L2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab.
    Shen G; Gao Q; Liu F; Zhang Y; Dai M; Zhao T; Cheng M; Xu T; Jin P; Yin W; Huang D; Weng H; Chen W; Ren H; Mu X; Wu X; Hu S
    Biochem Biophys Res Commun; 2020 Jun; 526(3):685-691. PubMed ID: 32248976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
    Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
    Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visinin-like 1, a novel target gene of the Wnt/β-catenin signaling pathway, is involved in apoptosis resistance in colorectal cancer.
    Tage H; Yamaguchi K; Nakagawa S; Kasuga S; Takane K; Furukawa Y; Ikenoue T
    Cancer Med; 2023 Jun; 12(12):13426-13437. PubMed ID: 37096864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.